Amneal Pharmaceuticals (AMRX) Other Non Operating Income (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Other Non Operating Income of -$3.5 million for Q1 2026, down 182.65% year-over-year from $4.2 million in Q1 2025, and down 9928.57% quarter-over-quarter from -$35000.0 in Q4 2025.
Amneal Pharmaceuticals (AMRX) Other Non Operating Income (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$3.5 million for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 182.65% year-over-year to -$3.5 million; the TTM figure through Mar 2026 stood at -$706000.0 (down 108.2% YoY), while the FY2025 annual figure was -$31.4 million, changed N/A from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$3.5 million, down from -$35000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $6.9 million in Q2 2022, with the low at -$15.1 million in Q4 2022.
- The 5-year median for Other Non Operating Income is $1.2 million (2025), against an average of -$12200.0.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income slumped 18834.48% in 2022, then soared 945.56% in 2024.
- Amneal Pharmaceuticals' Other Non Operating Income stood at -$15.1 million in 2022, then soared by 110.8% to $1.6 million in 2023, then surged by 167.98% to $4.4 million in 2024, then sank by 100.8% to -$35000.0 in 2025, then plunged by 9928.57% to -$3.5 million in 2026.
- Business Quant data shows AMRX's Other Non Operating Income at -$3.5 million in Q1 2026, -$35000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.95 Mn |
| Mar 31, 2026 | -3.51 Mn |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 4.25 Mn |
| Jun 30, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.07 Mn |
| Dec 31, 2023 | 1.63 Mn |
| Sep 30, 2023 | -2.94 Mn |
| Jun 30, 2023 | 417,000.00 |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | -15.06 Mn |
| Sep 30, 2022 | -5.49 Mn |
| Jun 30, 2022 | 6.94 Mn |
| Mar 31, 2022 | -2.01 Mn |
| Dec 31, 2021 | -8.70 Mn |
| Sep 30, 2021 | -29,000.00 |
| Mar 31, 2021 | 2.09 Mn |
| Dec 31, 2020 | 8.39 Mn |